Parilman & Associates Offering No-Cost Initial Consultations After Manufacturer Admission to Leaving Bleeding Incidents Out of Pradaxa Study

Share Article

The Pradaxa side effects lawyers at Parilman & Associates, whose law firm Web site URL can be found at, hereby announce that they are offering free initial consultations to consumers who may have been injured as a result of using Pradaxa. This offer comes in the wake of news that the makers of Pradaxa admitted that they omitted bleeding incidents from a study relating to the drug.

The Pradaxa side effects attorneys at Parilman & Associates represent clients across the United States who have been harmed by defective medications and defective medical devices. The firm has handled many different prescription drug lawsuits in the past, and the attorneys at Parilman & Associates hereby announce that they are offering free initial consultations to consumers who believe that they have been injured as a result of using the blood-thinning drug Pradaxa.

Boehringer Ingelheim is the manufacturer of Pradaxa, and a press release issued by the company itself recently stated that bleeding events that occurred during a large study of the drug were omitted from the results of that study. The study, known as the RE-LY study, was used to obtain approval from the FDA to market and sell the drug in the United States. A link to the press release issued by Boehringer Ingelheim can be found here.

Pradaxa was originally approved by the FDA in October of 2010 for use in the United States. The drug is a blood thinner that is used to prevent blood clots from forming. Pradaxa is used in particular by people who suffer from a condition known as atrial fibrillation, which is the medical term for an irregular heartbeat. Atrial fibrillation can lead to blood clots, and these blood clots can lead to strokes. Pradaxa helps to prevent this process from taking place.

Unfortunately, allegations and concerns regarding Pradaxa side effects began to arise and thousands of Pradaxa lawsuits were filed across the United States. According to an article that was published by Forbes on May 28, 2014 and entitled, “Boehringer Ingelheim Settles US Pradaxa Litigation For $650 Million,” the manufacturer believes that it has now resolved approximately 4,000 individual Pradaxa lawsuits. A link to that article can be found here. The case is In re Pradaxa Products Liability Litigation, 12-MD-02385, U.S. District Court, Southern District of Illinois (East St. Louis).

Given the recent news regarding the omission of bleeding incidents from the study of Pradaxa and the revelation that the manufacturer is settling many different Pradaxa lawsuits, consumers who have used the medication and who may have suffered as a result need to understand their legal rights. This is why the team at Parilman & Associates is offering free initial consultations to those who find themselves in this difficult position. Anyone who needs legal help is encouraged to either log onto to fill out the contact form or call 800-800-DRUG.

About Parilman & Associates
Parilman & Associates is a nationwide law firm that represents individuals and classes of consumers who have been injured by defective products. These products include defective medical devices and defective medications. The firm also represents clients who have been injured by exposure to asbestos and those who have been wrongfully harmed in different types of accidents. The firm’s Facebook profile can be found at The firm can also be reached by phone at 800-800-DRUG.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joshua Parilman
Visit website